AI-Powered Healthcare System to Fight the COVID-19 Pandemic on Federated Learning

AI-Powered Healthcare System to Fight the COVID-19 Pandemic on Federated Learning

S. Gnanamurthy, S. Raguvaran, B. Suresh Kumar, C. Santhosh Kumar, M. S. Hemawathi
Copyright: © 2024 |Pages: 25
DOI: 10.4018/979-8-3693-1082-3.ch010
OnDemand:
(Individual Chapters)
Available
$37.50
No Current Special Offers
TOTAL SAVINGS: $37.50

Abstract

The COVID-19 pandemic has caused several healthcare-related problems around the world. The pandemic has highlighted the shortcomings of employing current digital healthcare tools to manage public health emergencies. As a result, the COVID-19 issue has forced countries and research organizations to reassess healthcare delivery solutions to continue supplies while people stay at home or practice social isolation. Innumerable works of fiction have attempted to anticipate stock market returns and volatility using AI and machine learning. There is a dearth of a comprehensive overview of the various research orientations, discoveries, methodological methods, and contributions in the field of AI applications in finance. This research replicates realistic scenarios using a real COVID-19 dataset and evaluates issues such as model repetition delays, assuring the model's reliability and applicability. According to research findings, using this technology will enable medical professionals to detect coronavirus disease, achieve multiparty involvement in training, and improve data protection.
Chapter Preview
Top

1. Introduction

In response to the COVID-19 pandemic crisis, the scientific, hypothetical, medical, and data science groups have joined forces to swiftly assess novel AI paradigms that embrace concepts like free software, consistent research, and data archives and are quick, secure, and possibly encourage sharing data, instruction, and testing without the typical privacy and data control challenges of traditional and collaborative methods (Dayan et al., 2021). The epidemic has brought attention to the necessity of swiftly carrying out data partnerships that support the medical and scientific communities in reacting to pervasive and fast-developing global issues. The recent foray into the world of medical information by large technology organizations has brought attention to and maybe further compounded the ethical, regulatory, and legal difficulties of data sharing.

A specific illustration of these collaborations comes from our earlier research on an AI-based clinical decision support (CDS) model for SARS-COV-2. This CDS model was developed and verified at Mass General Brigham (MGB) utilising information from various healthcare systems. The inputs to the CDS model were chest X-ray (CXR) images, health indicators, demographic data, and laboratory values that had been shown in earlier publications to be predictive of outcomes in patients with COVID-19. Because it is widely accessible and frequently advised by guidelines such as those provided by the ACR22, the Fleischner The community, the WHO, national cardiac communities, National Health Ministry COVID instructions, and radiology societies globally, CXR was chosen as the examination input. In order to help with patient triage, the CDS model generates a score called CORISK that is related to the need for oxygen assistance. Medical experts, investigators, and companies have refocused their efforts to address unmet and urgent medical requirements brought on by the crisis, with amazing results. National regulatory agencies and an international spirit of cooperation have sped up and made it easier to recruit participants for research studies. The fields of data analytics and AI have traditionally encouraged open communication among front-line practitioners. It has been shown that healthcare practitioners choose models that were tested using their data. A large number of AI models to date, including the aforementioned CDS model, have been developed and verified on 'limited' data that frequently lacks variety, which may have led to overfitting and decreased generalizability. This can be minimized by adopting techniques like FL or communication learning to train on varied data from several places without centralizing the data. Without moving or disclosing the data, it travels to its original location. FL is a method for training AI systems using a range of data sets. While suitable for a variety of other sectors, FL has most recently been recommended for inter-institutional clinical studies.

Figure 1.

A total of three federated learning structures

979-8-3693-1082-3.ch010.f01

Figure 1's right side shows an illustration of FL with a hierarchical structure it retrieves the large training samples from the cloud and swiftly modifies the model using clients locally (Abreha et al., 2022). With the help of hierarchical FL and effective client-edge updates, communication via the cloud can be greatly minimized. As a result, compared to cloud-based FL, training runtimes and repetitions will be much reduced. In this article, the term “client” refers to hardware or nodes that do local training in ML to create the global FL network. As a result, the FL settings dictate who the clients are. The use of FL, which was initially developed for handheld devices, has swiftly evolved into many other uses, including working together among several organizations to train an example. Terms like “cross-device” and “cross-silo” are used to define various FL settings that can be employed by clients who are end devices and organizations, respectively. Although FL applications in EC contexts have been considered in previous surveys (Nguyen et al., 2021), FL deployment and issues with the EC paradigm has not been the subject of a thorough examination. This study's objective is to provide a systematic evaluation of the literature on FL deployment in EC environments, along with a categorization that pinpoints innovative fixes and other unresolved issues.

Complete Chapter List

Search this Book:
Reset